PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
MRK vs. AMGN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Performance

MRK vs. AMGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Merck & Co., Inc. (MRK) and Amgen Inc. (AMGN). The values are adjusted to include any dividend payments, if applicable.

20,000.00%40,000.00%60,000.00%80,000.00%100,000.00%120,000.00%140,000.00%JuneJulyAugustSeptemberOctoberNovember
15,216.48%
116,260.63%
MRK
AMGN

Returns By Period

In the year-to-date period, MRK achieves a -9.97% return, which is significantly lower than AMGN's 0.64% return. Both investments have delivered pretty close results over the past 10 years, with MRK having a 8.63% annualized return and AMGN not far ahead at 8.71%.


MRK

YTD

-9.97%

1M

-12.78%

6M

-25.65%

1Y

-3.07%

5Y (annualized)

6.72%

10Y (annualized)

8.63%

AMGN

YTD

0.64%

1M

-11.83%

6M

-8.60%

1Y

9.22%

5Y (annualized)

7.88%

10Y (annualized)

8.71%

Fundamentals


MRKAMGN
Market Cap$249.37B$172.98B
EPS$4.78$7.26
PE Ratio20.6241.16
PEG Ratio0.072.31
Total Revenue (TTM)$63.22B$32.43B
Gross Profit (TTM)$48.80B$19.57B
EBITDA (TTM)$18.85B$10.69B

Key characteristics


MRKAMGN
Sharpe Ratio-0.120.31
Sortino Ratio-0.020.62
Omega Ratio1.001.09
Calmar Ratio-0.090.42
Martin Ratio-0.261.00
Ulcer Index9.59%7.74%
Daily Std Dev20.65%25.17%
Max Drawdown-68.63%-78.04%
Current Drawdown-27.08%-15.94%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Correlation

-0.50.00.51.00.3

The correlation between MRK and AMGN is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Risk-Adjusted Performance

MRK vs. AMGN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Merck & Co., Inc. (MRK) and Amgen Inc. (AMGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for MRK, currently valued at -0.15, compared to the broader market-4.00-2.000.002.00-0.150.31
The chart of Sortino ratio for MRK, currently valued at -0.06, compared to the broader market-4.00-2.000.002.004.00-0.060.62
The chart of Omega ratio for MRK, currently valued at 0.99, compared to the broader market0.501.001.502.000.991.09
The chart of Calmar ratio for MRK, currently valued at -0.11, compared to the broader market0.002.004.006.00-0.110.42
The chart of Martin ratio for MRK, currently valued at -0.31, compared to the broader market0.0010.0020.0030.00-0.311.00
MRK
AMGN

The current MRK Sharpe Ratio is -0.12, which is lower than the AMGN Sharpe Ratio of 0.31. The chart below compares the historical Sharpe Ratios of MRK and AMGN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Rolling 12-month Sharpe Ratio0.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
-0.15
0.31
MRK
AMGN

Dividends

MRK vs. AMGN - Dividend Comparison

MRK's dividend yield for the trailing twelve months is around 3.20%, which matches AMGN's 3.17% yield.


TTM20232022202120202019201820172016201520142013
MRK
Merck & Co., Inc.
3.20%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%3.12%3.46%
AMGN
Amgen Inc.
3.17%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%1.53%1.65%

Drawdowns

MRK vs. AMGN - Drawdown Comparison

The maximum MRK drawdown since its inception was -68.63%, smaller than the maximum AMGN drawdown of -78.04%. Use the drawdown chart below to compare losses from any high point for MRK and AMGN. For additional features, visit the drawdowns tool.


-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-27.08%
-15.94%
MRK
AMGN

Volatility

MRK vs. AMGN - Volatility Comparison

The current volatility for Merck & Co., Inc. (MRK) is 5.29%, while Amgen Inc. (AMGN) has a volatility of 9.25%. This indicates that MRK experiences smaller price fluctuations and is considered to be less risky than AMGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%14.00%JuneJulyAugustSeptemberOctoberNovember
5.29%
9.25%
MRK
AMGN

Financials

MRK vs. AMGN - Financials Comparison

This section allows you to compare key financial metrics between Merck & Co., Inc. and Amgen Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items